CSHL 2026 Conference on Gene Expression and Signaling in the Immune System
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
Cold Spring Harbor Laboratory Conference GENE EXPRESSION AND SIGNALING IN THE IMMUNE SYSTEM March 3-7,2026 ABSTRACT The proposed meeting on Gene Expression and Signaling in the Immune System, to be held in March, 2026, will focus on the most recent advances in this rapidly moving field. The meeting will be open, with attendance limited only by the facilities available to a maximum of ~425 participants. Oral presentations will be delivered by both invited speakers and those selected from submitted abstracts. This ensures the participation of junior and senior leaders in the field and the presentation of the most exciting results emerging at the time of the meeting. A particular emphasis will be made to ensure that a substantial number of speakers will be advanced trainees or junior PIs. The oral presentations will be complemented by poster presentations in two sessions, also selected from submitted abstracts. The areas to be covered in the 2026 meeting include 1) Regulation of gene expression; 2) Differentiation; 3) Signaling at the membrane; 4) Intracellular signaling; 5) Intercellular communication; 6) Host:microbe interactions; 7) Immune responses; and 8) Tissue-immune communication (immunophysiology). Rather than focusing on one particular type of immune cell or disease process, the meeting will highlight mechanistic approaches that aim to rigorously advance our knowledge of how the processes of signal transduction and gene regulation operate within the immune system at different scales. Ample opportunity is provided for the presentation of important, late-breaking findings. The meeting format ensures and encourages highly productive discussions, particularly during meals and in poster sessions. The meeting will foster interactions among immunologists working in related areas and provide a forum for the development of new ideas and approaches for current and future investigations of regulation of signaling and gene expression in the immune system.
Grant Summary
CSHL 2026 Conference on Gene Expression and Signaling in the Immune System is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $10K for university, nonprofit, healthcare org. Applications are due 2027-01-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $10K
2027-01-31
- 1Confirm your organization is eligible for CSHL 2026 Conference on Gene Expression and Signaling in the Immune System from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
CSHL 2026 Conference on Gene Expression and Signaling in the Immune System: Frequently Asked Questions
Who is eligible for the CSHL 2026 Conference on Gene Expression and Signaling in the Immune System?
CSHL 2026 Conference on Gene Expression and Signaling in the Immune System is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the CSHL 2026 Conference on Gene Expression and Signaling in the Immune System provide?
CSHL 2026 Conference on Gene Expression and Signaling in the Immune System provides up to $10K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the CSHL 2026 Conference on Gene Expression and Signaling in the Immune System deadline?
Applications for CSHL 2026 Conference on Gene Expression and Signaling in the Immune System are due 2027-01-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the CSHL 2026 Conference on Gene Expression and Signaling in the Immune System?
To apply for CSHL 2026 Conference on Gene Expression and Signaling in the Immune System, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.